$NVCR Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in NovoCure Ltd.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of all insider trading transactions in NovoCure Ltd. Get notifications about new insider transactions in NovoCure Ltd for free.

Page:   1 2 3 4 5 ... 10 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 11 2021NVCRNovoCure LtdMcCoy Sherilyn SDirectorOption ExerciseA211.891,499317,6231,499
Jun 11 2021NVCRNovoCure LtdMcCoy Sherilyn SDirectorGrantA0.0081406,7145.9 K to 6.7 K (+13.80 %)
May 14 2021NVCRNovoCure LtdBenaim ElyChief Medical Offic ...SellS180.481,943350,67329,05431 K to 29.1 K (-6.27 %)
May 12 2021NVCRNovoCure LtdWeinberg UriChief Science Offic ...Option ExerciseM47.563,846182,9163,845
May 12 2021NVCRNovoCure LtdWeinberg UriChief Science Offic ...SellS189.651,804342,12931,66733.5 K to 31.7 K (-5.39 %)
May 12 2021NVCRNovoCure LtdWeinberg UriChief Science Offic ...SellS189.653,846729,39433,47137.3 K to 33.5 K (-10.31 %)
May 12 2021NVCRNovoCure LtdWeinberg UriChief Science Offic ...BuyM47.563,846182,91637,31733.5 K to 37.3 K (+11.49 %)
May 06 2021NVCRNovoCure LtdShah PriteshChief Commercial Of ...SellS199.671,290257,574101,272102.6 K to 101.3 K (-1.26 %)
Apr 15 2021NVCRNovoCure LtdDOYLE WILLIAM FExecutive ChairmanSellS216.69600130,016555,393556 K to 555.4 K (-0.11 %)
Apr 15 2021NVCRNovoCure LtdDOYLE WILLIAM FExecutive ChairmanSellS214.67500107,333555,993556.5 K to 556 K (-0.09 %)
Apr 15 2021NVCRNovoCure LtdDOYLE WILLIAM FExecutive ChairmanSellS213.351,500320,021556,493558 K to 556.5 K (-0.27 %)
Apr 15 2021NVCRNovoCure LtdDOYLE WILLIAM FExecutive ChairmanSellS211.28600126,766557,993558.6 K to 558 K (-0.11 %)
Apr 15 2021NVCRNovoCure LtdDOYLE WILLIAM FExecutive ChairmanSellS210.18521109,504558,593559.1 K to 558.6 K (-0.09 %)
Apr 15 2021NVCRNovoCure LtdDOYLE WILLIAM FExecutive ChairmanSellS209.342,200460,555559,114561.3 K to 559.1 K (-0.39 %)
Apr 15 2021NVCRNovoCure LtdDOYLE WILLIAM FExecutive ChairmanSellS207.804,500935,118561,314565.8 K to 561.3 K (-0.80 %)
Apr 15 2021NVCRNovoCure LtdDOYLE WILLIAM FExecutive ChairmanSellS206.351,284264,956565,814567.1 K to 565.8 K (-0.23 %)
Apr 15 2021NVCRNovoCure LtdDOYLE WILLIAM FExecutive ChairmanSellS205.431,600328,690567,098568.7 K to 567.1 K (-0.28 %)
Apr 15 2021NVCRNovoCure LtdDOYLE WILLIAM FExecutive ChairmanSellS204.281,972402,834568,698570.7 K to 568.7 K (-0.35 %)
Apr 15 2021NVCRNovoCure LtdDOYLE WILLIAM FExecutive ChairmanSellS203.252,555519,311570,670573.2 K to 570.7 K (-0.45 %)
Apr 15 2021NVCRNovoCure LtdDOYLE WILLIAM FExecutive ChairmanSellS202.164,388887,069573,225577.6 K to 573.2 K (-0.76 %)
Apr 15 2021NVCRNovoCure LtdDOYLE WILLIAM FExecutive ChairmanSellS201.554,125831,377577,613581.7 K to 577.6 K (-0.71 %)
Apr 15 2021NVCRNovoCure LtdDOYLE WILLIAM FExecutive ChairmanSellS199.714,338866,355581,738586.1 K to 581.7 K (-0.74 %)
Apr 15 2021NVCRNovoCure LtdDOYLE WILLIAM FExecutive ChairmanSellS198.9810,5632,101,794586,076596.6 K to 586.1 K (-1.77 %)
Apr 15 2021NVCRNovoCure LtdDOYLE WILLIAM FExecutive ChairmanSellS197.8313,6122,692,876596,639610.3 K to 596.6 K (-2.23 %)
Apr 15 2021NVCRNovoCure LtdDOYLE WILLIAM FExecutive ChairmanSellS197.0024,3384,794,659610,251634.6 K to 610.3 K (-3.84 %)
Apr 15 2021NVCRNovoCure LtdDOYLE WILLIAM FExecutive ChairmanSellS196.078,8141,728,187634,589643.4 K to 634.6 K (-1.37 %)
Apr 15 2021NVCRNovoCure LtdDOYLE WILLIAM FExecutive ChairmanSellS194.941,600311,904643,403645 K to 643.4 K (-0.25 %)
Apr 15 2021NVCRNovoCure LtdDOYLE WILLIAM FExecutive ChairmanSellS193.572,090404,563645,003647.1 K to 645 K (-0.32 %)
Apr 15 2021NVCRNovoCure LtdDOYLE WILLIAM FExecutive ChairmanSellS192.521,900365,796647,093649 K to 647.1 K (-0.29 %)
Apr 15 2021NVCRNovoCure LtdDOYLE WILLIAM FExecutive ChairmanSellS191.261,400267,768648,993650.4 K to 649 K (-0.22 %)
Apr 15 2021NVCRNovoCure LtdDanziger AsafChief Executive Off ...SellS196.3497,97319,236,3238,184106.2 K to 8.2 K (-92.29 %)
Apr 15 2021NVCRNovoCure LtdLEUNG GABRIELDirectorOption ExerciseM31.456,000188,7006,345
Apr 15 2021NVCRNovoCure LtdLEUNG GABRIELDirectorSellS200.002,500500,00072,04574.5 K to 72 K (-3.35 %)
Apr 15 2021NVCRNovoCure LtdLEUNG GABRIELDirectorSellS198.013,500693,03574,54578 K to 74.5 K (-4.48 %)
Apr 15 2021NVCRNovoCure LtdLEUNG GABRIELDirectorBuyM31.456,000188,70078,04572 K to 78 K (+8.33 %)
Apr 15 2021NVCRNovoCure LtdBenaim ElyChief Medical Offic ...Option ExerciseM69.373,474240,99119,404
Apr 15 2021NVCRNovoCure LtdBenaim ElyChief Medical Offic ...Option ExerciseM83.3065154,2283,904
Apr 15 2021NVCRNovoCure LtdBenaim ElyChief Medical Offic ...Option ExerciseM47.561,83387,17710,998
Apr 15 2021NVCRNovoCure LtdBenaim ElyChief Medical Offic ...SellS200.003,474694,80033,25936.7 K to 33.3 K (-9.46 %)
Apr 15 2021NVCRNovoCure LtdBenaim ElyChief Medical Offic ...BuyM69.373,474240,99136,73333.3 K to 36.7 K (+10.45 %)
Apr 15 2021NVCRNovoCure LtdBenaim ElyChief Medical Offic ...SellS200.00651130,20033,25933.9 K to 33.3 K (-1.92 %)
Apr 15 2021NVCRNovoCure LtdBenaim ElyChief Medical Offic ...BuyM83.3065154,22833,91033.3 K to 33.9 K (+1.96 %)
Apr 15 2021NVCRNovoCure LtdBenaim ElyChief Medical Offic ...SellS200.001,833366,60033,25935.1 K to 33.3 K (-5.22 %)
Apr 15 2021NVCRNovoCure LtdBenaim ElyChief Medical Offic ...BuyM47.561,83387,17735,09233.3 K to 35.1 K (+5.51 %)
Apr 08 2021NVCRNovoCure LtdGROENHUYSEN WILHELMUS CMChief Operating Off ...SellS72.223,670265,029150,014153.7 K to 150 K (-2.39 %)
Mar 10 2021NVCRNovoCure LtdShah PriteshChief Commercial Of ...SellS131.093,524461,961101,272104.8 K to 101.3 K (-3.36 %)
Mar 10 2021NVCRNovoCure LtdShah PriteshChief Commercial Of ...SellS130.812,627343,627104,796107.4 K to 104.8 K (-2.45 %)
Mar 10 2021NVCRNovoCure LtdCordova AshleyChief Financial Off ...SellS130.81765100,06735,89336.7 K to 35.9 K (-2.09 %)
Mar 10 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS130.812,404314,45867,71470.1 K to 67.7 K (-3.43 %)
Mar 10 2021NVCRNovoCure LtdLeonard Frank XChief Development O ...SellS130.81765100,06790,04590.8 K to 90 K (-0.84 %)
Mar 10 2021NVCRNovoCure LtdGROENHUYSEN WILHELMUS CMChief Operating Off ...SellS130.813,004392,941153,684156.7 K to 153.7 K (-1.92 %)
Mar 09 2021NVCRNovoCure LtdShah PriteshChief Commercial Of ...Option ExerciseM7.1513,987100,0070
Mar 09 2021NVCRNovoCure LtdShah PriteshChief Commercial Of ...SellS131.534,550598,462107,423112 K to 107.4 K (-4.06 %)
Mar 09 2021NVCRNovoCure LtdShah PriteshChief Commercial Of ...BuyM7.1513,987100,007111,97398 K to 112 K (+14.27 %)
Mar 09 2021NVCRNovoCure LtdBenaim ElyChief Medical Offic ...SellS131.532,918383,80533,25936.2 K to 33.3 K (-8.07 %)
Mar 08 2021NVCRNovoCure LtdGROENHUYSEN WILHELMUS CMChief Operating Off ...SellS137.553,854530,133156,688160.5 K to 156.7 K (-2.40 %)
Mar 08 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS137.553,084424,21770,11873.2 K to 70.1 K (-4.21 %)
Mar 08 2021NVCRNovoCure LtdLeonard Frank XChief Development O ...SellS137.5556777,99390,81091.4 K to 90.8 K (-0.62 %)
Mar 08 2021NVCRNovoCure LtdCordova AshleyChief Financial Off ...GiftG0.00910036,65837.6 K to 36.7 K (-2.42 %)
Mar 08 2021NVCRNovoCure LtdCordova AshleyChief Financial Off ...SellS137.5556777,99337,56838.1 K to 37.6 K (-1.49 %)
Mar 05 2021NVCRNovoCure LtdBenaim ElyChief Medical Offic ...Option ExerciseM69.373,475241,06122,878
Mar 05 2021NVCRNovoCure LtdBenaim ElyChief Medical Offic ...SellS137.551,888259,70236,17738.1 K to 36.2 K (-4.96 %)
Mar 05 2021NVCRNovoCure LtdBenaim ElyChief Medical Offic ...SellS150.783,475523,96138,06541.5 K to 38.1 K (-8.37 %)
Mar 05 2021NVCRNovoCure LtdBenaim ElyChief Medical Offic ...BuyM69.373,475241,06141,54038.1 K to 41.5 K (+9.13 %)
Mar 05 2021NVCRNovoCure LtdShah PriteshChief Commercial Of ...SellS137.552,658365,61997,986100.6 K to 98 K (-2.64 %)
Mar 05 2021NVCRNovoCure LtdShah PriteshChief Commercial Of ...SellS150.782,174327,796100,644102.8 K to 100.6 K (-2.11 %)
Mar 04 2021NVCRNovoCure LtdWeinberg UriChief Science Offic ...Option ExerciseA153.0916,0032,449,89916,003
Mar 04 2021NVCRNovoCure LtdWeinberg UriChief Science Offic ...GrantA0.008,709036,30627.6 K to 36.3 K (+31.56 %)
Mar 04 2021NVCRNovoCure LtdBenaim ElyChief Medical Offic ...Option ExerciseA153.0916,0032,449,89916,003
Mar 04 2021NVCRNovoCure LtdBenaim ElyChief Medical Offic ...GrantA0.008,709038,06529.4 K to 38.1 K (+29.67 %)
Mar 04 2021NVCRNovoCure LtdCordova AshleyChief Financial Off ...Option ExerciseA153.0920,0043,062,41220,004
Mar 04 2021NVCRNovoCure LtdCordova AshleyChief Financial Off ...GrantA0.0010,886038,13527.2 K to 38.1 K (+39.95 %)
Mar 04 2021NVCRNovoCure LtdCordova AshleyChief Financial Off ...SellS152.0542865,07927,24927.7 K to 27.2 K (-1.55 %)
Mar 04 2021NVCRNovoCure LtdGROENHUYSEN WILHELMUS CMChief Operating Off ...Option ExerciseA153.0923,0043,521,68223,004
Mar 04 2021NVCRNovoCure LtdGROENHUYSEN WILHELMUS CMChief Operating Off ...GrantA0.0012,5190160,542148 K to 160.5 K (+8.46 %)
Mar 04 2021NVCRNovoCure LtdGROENHUYSEN WILHELMUS CMChief Operating Off ...SellS152.052,392363,711148,023150.4 K to 148 K (-1.59 %)
Mar 04 2021NVCRNovoCure LtdScannell Timothy JDirectorOption ExerciseA153.097,9291,213,8517,929
Mar 04 2021NVCRNovoCure LtdShah PriteshChief Commercial Of ...Option ExerciseA153.0920,0043,062,41220,004
Mar 04 2021NVCRNovoCure LtdShah PriteshChief Commercial Of ...GrantA0.0010,8860102,81891.9 K to 102.8 K (+11.84 %)
Mar 04 2021NVCRNovoCure LtdShah PriteshChief Commercial Of ...SellS152.05912138,67291,93292.8 K to 91.9 K (-0.98 %)
Mar 04 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselOption ExerciseA153.0919,0042,909,32219,004
Mar 04 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselGrantA0.0010,342073,20262.9 K to 73.2 K (+16.45 %)
Mar 04 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS152.052,355358,08562,86065.2 K to 62.9 K (-3.61 %)
Mar 02 2021NVCRNovoCure LtdShah PriteshChief Commercial Of ...Option ExerciseM0.003,08600
Mar 02 2021NVCRNovoCure LtdShah PriteshChief Commercial Of ...BuyM149.103,086460,12392,84489.8 K to 92.8 K (+3.44 %)
Mar 02 2021NVCRNovoCure LtdDanziger AsafChief Executive Off ...Option ExerciseM0.009,25900
Mar 02 2021NVCRNovoCure LtdDanziger AsafChief Executive Off ...BuyM149.109,2591,380,517206,944197.7 K to 206.9 K (+4.68 %)
Mar 02 2021NVCRNovoCure LtdLeonard Frank XChief Development O ...Option ExerciseM0.001,46500
Mar 02 2021NVCRNovoCure LtdLeonard Frank XChief Development O ...BuyM149.101,465218,43283,09881.6 K to 83.1 K (+1.79 %)
Mar 02 2021NVCRNovoCure LtdGROENHUYSEN WILHELMUS CMChief Operating Off ...Option ExerciseM0.007,71500
Mar 02 2021NVCRNovoCure LtdGROENHUYSEN WILHELMUS CMChief Operating Off ...BuyM149.107,7151,150,307150,415142.7 K to 150.4 K (+5.41 %)
Feb 24 2021NVCRNovoCure LtdWeinberg UriChief Science Offic ...Option ExerciseM7.156,50046,4750
Feb 24 2021NVCRNovoCure LtdWeinberg UriChief Science Offic ...SellS175.506,5001,140,75027,59734.1 K to 27.6 K (-19.06 %)
Feb 24 2021NVCRNovoCure LtdWeinberg UriChief Science Offic ...BuyM7.156,50046,47534,09727.6 K to 34.1 K (+23.55 %)
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselOption ExerciseM14.3736,396523,0110
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS179.301,200215,16159,66060.9 K to 59.7 K (-1.97 %)
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS178.50900160,64860,86061.8 K to 60.9 K (-1.46 %)
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS177.332,841503,79761,76064.6 K to 61.8 K (-4.40 %)
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS176.2240070,48664,60165 K to 64.6 K (-0.62 %)
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS175.282,200385,61465,00167.2 K to 65 K (-3.27 %)
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS174.062,502435,50667,20169.7 K to 67.2 K (-3.59 %)
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS173.101,700294,27069,70371.4 K to 69.7 K (-2.38 %)
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS171.9011,9852,060,25771,40383.4 K to 71.4 K (-14.37 %)
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS171.324,826826,78183,38888.2 K to 83.4 K (-5.47 %)
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS169.932,542431,97088,21490.8 K to 88.2 K (-2.80 %)
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS169.191,800304,54990,75692.6 K to 90.8 K (-1.94 %)
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS167.773,500587,20992,55696.1 K to 92.6 K (-3.64 %)
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS179.37900161,43196,05697 K to 96.1 K (-0.93 %)
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS178.681,000178,67596,95698 K to 97 K (-1.02 %)
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS177.312,200390,07197,956100.2 K to 98 K (-2.20 %)
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS175.9840070,392100,156100.6 K to 100.2 K (-0.40 %)
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS175.141,700297,731100,556102.3 K to 100.6 K (-1.66 %)
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS173.881,600278,205102,256103.9 K to 102.3 K (-1.54 %)
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS172.951,300224,838103,856105.2 K to 103.9 K (-1.24 %)
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS171.8610,1101,737,494105,156115.3 K to 105.2 K (-8.77 %)
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS171.182,761472,639115,266118 K to 115.3 K (-2.34 %)
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS169.762,148364,644118,027120.2 K to 118 K (-1.79 %)
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS168.80800135,043120,175121 K to 120.2 K (-0.66 %)
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS167.762,499419,235120,975123.5 K to 121 K (-2.02 %)
Jan 19 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselBuyM14.3736,396523,011123,47487.1 K to 123.5 K (+41.80 %)
Jan 08 2021NVCRNovoCure LtdGROENHUYSEN WILHELMUS CMChief Operating Off ...GrantA50.67934,712142,700142.6 K to 142.7 K (+0.07 %)
Dec 22 2020NVCRNovoCure LtdBenaim ElyChief Medical Offic ...Option ExerciseM83.3065154,2284,555
Dec 22 2020NVCRNovoCure LtdBenaim ElyChief Medical Offic ...Option ExerciseM47.561,83387,17712,831
Dec 22 2020NVCRNovoCure LtdBenaim ElyChief Medical Offic ...SellS156.71651102,01829,35630 K to 29.4 K (-2.17 %)
Dec 22 2020NVCRNovoCure LtdBenaim ElyChief Medical Offic ...BuyM83.3065154,22830,00729.4 K to 30 K (+2.22 %)
Dec 22 2020NVCRNovoCure LtdBenaim ElyChief Medical Offic ...SellS156.711,833287,24929,35631.2 K to 29.4 K (-5.88 %)
Dec 22 2020NVCRNovoCure LtdBenaim ElyChief Medical Offic ...BuyM47.561,83387,17731,18929.4 K to 31.2 K (+6.24 %)
Dec 22 2020NVCRNovoCure LtdHILLEMAN JERYL LDirectorSellS166.402,500416,0003,4005.9 K to 3.4 K (-42.37 %)
Dec 22 2020NVCRNovoCure LtdDanziger AsafChief Executive Off ...Option ExerciseM22.00103,9552,287,0100
Dec 22 2020NVCRNovoCure LtdDanziger AsafChief Executive Off ...Option ExerciseM22.00103,9552,287,010103,955
Dec 22 2020NVCRNovoCure LtdDanziger AsafChief Executive Off ...SellS166.0840066,432197,632198 K to 197.6 K (-0.20 %)
Dec 22 2020NVCRNovoCure LtdDanziger AsafChief Executive Off ...SellS164.96971160,175198,032199 K to 198 K (-0.49 %)
Dec 22 2020NVCRNovoCure LtdDanziger AsafChief Executive Off ...SellS163.3553687,555199,003199.5 K to 199 K (-0.27 %)
Dec 22 2020NVCRNovoCure LtdDanziger AsafChief Executive Off ...SellS162.351,700276,000199,539201.2 K to 199.5 K (-0.84 %)
Dec 22 2020NVCRNovoCure LtdDanziger AsafChief Executive Off ...SellS161.114,014646,679201,239205.3 K to 201.2 K (-1.96 %)
Dec 22 2020NVCRNovoCure LtdDanziger AsafChief Executive Off ...SellS160.2711,6861,872,915205,253216.9 K to 205.3 K (-5.39 %)
Dec 22 2020NVCRNovoCure LtdDanziger AsafChief Executive Off ...SellS159.274,790762,903216,939221.7 K to 216.9 K (-2.16 %)
Dec 22 2020NVCRNovoCure LtdDanziger AsafChief Executive Off ...SellS158.0610,0771,592,811221,729231.8 K to 221.7 K (-4.35 %)
Dec 22 2020NVCRNovoCure LtdDanziger AsafChief Executive Off ...SellS157.0123,6013,705,522231,806255.4 K to 231.8 K (-9.24 %)
Dec 22 2020NVCRNovoCure LtdDanziger AsafChief Executive Off ...SellS156.0824,9733,897,861255,407280.4 K to 255.4 K (-8.91 %)
Dec 22 2020NVCRNovoCure LtdDanziger AsafChief Executive Off ...SellS155.2321,2073,292,005280,380301.6 K to 280.4 K (-7.03 %)
Dec 22 2020NVCRNovoCure LtdDanziger AsafChief Executive Off ...BuyM22.00103,9552,287,010301,587197.6 K to 301.6 K (+52.60 %)
Dec 22 2020NVCRNovoCure LtdDanziger AsafChief Executive Off ...SellS166.1720033,234197,632197.8 K to 197.6 K (-0.10 %)
Dec 22 2020NVCRNovoCure LtdDanziger AsafChief Executive Off ...SellS165.38700115,768197,832198.5 K to 197.8 K (-0.35 %)
Dec 22 2020NVCRNovoCure LtdDanziger AsafChief Executive Off ...SellS164.1150082,055198,532199 K to 198.5 K (-0.25 %)
Dec 22 2020NVCRNovoCure LtdDanziger AsafChief Executive Off ...SellS162.971,300211,860199,032200.3 K to 199 K (-0.65 %)
Dec 22 2020NVCRNovoCure LtdDanziger AsafChief Executive Off ...SellS162.171,426231,259200,332201.8 K to 200.3 K (-0.71 %)
Dec 22 2020NVCRNovoCure LtdDanziger AsafChief Executive Off ...SellS160.993,500563,479201,758205.3 K to 201.8 K (-1.71 %)
Dec 22 2020NVCRNovoCure LtdDanziger AsafChief Executive Off ...SellS160.2512,0921,937,743205,258217.4 K to 205.3 K (-5.56 %)
Dec 22 2020NVCRNovoCure LtdDanziger AsafChief Executive Off ...SellS159.324,500716,954217,350221.9 K to 217.4 K (-2.03 %)

Page:   1 2 3 4 5 ... 10 next >

Contact us | Follow us on Twitter